These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 10080337)

  • 21. Primary replacement for the management of exposed orbital implant.
    Curragh DS; Kamalarajah S; Lacey B; White ST; McNab AA; Kalantzis G; Dolman PJ; Selva D; Rajak SN
    Orbit; 2019 Dec; 38(6):461-467. PubMed ID: 30706748
    [No Abstract]   [Full Text] [Related]  

  • 22. Complication of an Ahmed glaucoma valve implant: tube exposure with methicillin-resistant Staphylococcus aureus infection.
    Pansegrau ML; Mengarelli E; Dersu II
    Digit J Ophthalmol; 2015; 21(4):1-9. PubMed ID: 27330471
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nontuberculous Mycobacterial Infection after Removal of the Exposed Hydroxyapatite.
    Song YY; You IC; Ahn M
    Korean J Ophthalmol; 2017 Aug; 31(4):366-367. PubMed ID: 28752699
    [No Abstract]   [Full Text] [Related]  

  • 24. Bovine hydroxyapatite orbital implant: a preliminary report.
    Perry JD; Goldberg RA; McCann JD; Shorr N; Engstrom R; Tong J
    Ophthalmic Plast Reconstr Surg; 2002 Jul; 18(4):268-74. PubMed ID: 12142759
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hydroxyapatite ocular implant and non-integrated implants in eviscerated patients.
    Gradinaru S; Popescu V; Leasu C; Pricopie S; Yasin S; Ciuluvica R; Ungureanu E
    J Med Life; 2015; 8(1):90-3. PubMed ID: 25914747
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Delayed onset porous polyethylene implant-related inflammation after orbital blowout fracture repair: four case reports.
    Aryasit O; Ng DS; Goh ASC; Woo KI; Kim YD
    BMC Ophthalmol; 2016 Jul; 16():94. PubMed ID: 27387333
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Unwrapped hydroxyapatite orbital implants: our experience in 347 cases.
    Sobti MM; Shams F; Jawaheer L; Cauchi P; Chadha V
    Eye (Lond); 2020 Apr; 34(4):675-682. PubMed ID: 31527766
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chronic Staphylococcus aureus infection leading to pyogenic granuloma and preventing socket re-epithelialization after orbital exenteration.
    Hatton MP; Durand ML; Rubin PA
    Ophthalmic Plast Reconstr Surg; 2005 May; 21(3):236-8. PubMed ID: 15942503
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Complications associated with pegging hydroxyapatite orbital implants.
    Jordan DR; Chan S; Mawn L; Gilberg S; Dean T; Brownstein S; Hill VE
    Ophthalmology; 1999 Mar; 106(3):505-12. PubMed ID: 10080206
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hydroxyapatite orbital implant exposure in children.
    Nolan LM; O'keefe M; Lanigan B
    J AAPOS; 2003 Oct; 7(5):345-8. PubMed ID: 14566317
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of the exposure rate of wrapped hydroxyapatite (Bio-Eye) versus unwrapped porous polyethylene (Medpor) orbital implants in enucleated patients.
    Tabatabaee Z; Mazloumi M; Rajabi MT; Khalilzadeh O; Kassaee A; Moghimi S; Eftekhar H; Goldberg RA
    Ophthalmic Plast Reconstr Surg; 2011; 27(2):114-8. PubMed ID: 20829725
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Contrast-enhanced magnetic resonance imaging of fibrovascular tissue ingrowth within synthetic hydroxyapatite orbital implants in children.
    Galluzzi P; De Francesco S; Giacalone G; Cerase A; Monti L; Vallone IM; Lazzeretti L; Venturi C; Hadjistilianou T
    Eur J Ophthalmol; 2011; 21(5):521-8. PubMed ID: 21279974
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chronic exposure of hydroxyapatite orbital implants: cilia implantation and epithelial downgrowth.
    Kim JW; Kikkawa DO; Aboy A; Glasgow BJ
    Ophthalmic Plast Reconstr Surg; 2000 May; 16(3):216-22. PubMed ID: 10826763
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Abscessed porous polyethylene (Medpor) orbital implant: a case report.
    Musadiq M; Bhatt R; Mudhar HS; Sandramouli S
    Orbit; 2008; 27(2):127-9. PubMed ID: 18415874
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lack of complications of the hydroxyapatite orbital implant in 250 consecutive cases.
    Shields CL; Shields JA; De Potter P; Singh AD
    Trans Am Ophthalmol Soc; 1993; 91():177-89; discussion 189-95. PubMed ID: 8140690
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Delayed-onset of Pseudomonas infection in a hydroxyapatite orbital implant: a case report.
    Yeh LK; Kao SC; Tsai CC; Hsu WM; Liu JH
    Zhonghua Yi Xue Za Zhi (Taipei); 1999 Nov; 62(11):832-7. PubMed ID: 10575814
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Experience with 120 synthetic hydroxyapatite implants (FCI3).
    Jordan DR; Bawazeer A
    Ophthalmic Plast Reconstr Surg; 2001 May; 17(3):184-90. PubMed ID: 11388384
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The wayward implant: orbital silicone plate extrusion associated with squamous epithelial downgrowth and infection.
    Klisovic DD; Katz SE; Lubow M
    Orbit; 2002 Jun; 21(2):149-54. PubMed ID: 12029571
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Primary banked scleral patch graft in the prevention of exposure of hydroxyapatite orbital implants.
    Inkster CF; Ng SG; Leatherbarrow B
    Ophthalmology; 2002 Feb; 109(2):389-92. PubMed ID: 11825828
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Management of tissue breakdown and exposure associated with orbital hydroxyapatite implants.
    el-Shahed FS; Sherif MM; Ali AT
    Ophthalmic Plast Reconstr Surg; 1995 Jun; 11(2):91-4. PubMed ID: 7654623
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.